カテゴリー： QYResearch, 世界

世界のヤヌスキナーゼ（JAK）阻害剤産業：成長傾向・競合分析2019-2025

【英語タイトル】Global Janus Kinase (JAK) Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料（DATA909X01275）・商品コード：DATA909X01275
・発行会社（調査会社）：QYResearch
・発行日：2019年11月22日（※2024年版があります。お問い合わせください）
・ページ数：117
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥725,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,087,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,450,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートでは、世界のヤヌスキナーゼ（JAK）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ヤヌスキナーゼ（JAK）阻害剤の種類別には、自己免疫疾患、腫瘍学に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・ヤヌスキナーゼ（JAK）阻害剤の種類別市場規模：自己免疫疾患、腫瘍学
・ヤヌスキナーゼ（JAK）阻害剤の用途別市場規模：クリニック、病院
・ヤヌスキナーゼ（JAK）阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Astellas Pharma, Inc.、Eli Lilly and Co.、Incyte Corp.、Novartis AG、Pfizer Inc.
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Janus Kinase (JAK) Inhibitors.

This study researches the market size of Janus Kinase (JAK) Inhibitors, presents the global Janus Kinase (JAK) Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Janus Kinase (JAK) Inhibitors in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Janus Kinase (JAK) Inhibitors for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Eli Lilly and Co.
Incyte Corp.
Novartis AG
Pfizer Inc.
…

Market Segment by Product Type
Autoimmune disorders
Oncology

Market Segment by Application
Clinics
Hospitals

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Asia-Pacific
China
Japan
South Korea
Central & South America
Brazil
Middle East & Africa
Mid East
South Africa

The study objectives are:
To analyze and research the global Janus Kinase (JAK) Inhibitors status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Janus Kinase (JAK) Inhibitors manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Janus Kinase (JAK) Inhibitors are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type
1.3.2 Autoimmune disorders
1.3.3 Oncology
1.4 Market Segment by Application
1.4.1 Global Janus Kinase (JAK) Inhibitors Market Share by Application (2019-2025)
1.4.2 Clinics
1.4.3 Hospitals
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Janus Kinase (JAK) Inhibitors Market Size
2.1.1 Global Janus Kinase (JAK) Inhibitors Revenue 2014-2025
2.1.2 Global Janus Kinase (JAK) Inhibitors Sales 2014-2025
2.2 Janus Kinase (JAK) Inhibitors Growth Rate by Regions
2.2.1 Global Janus Kinase (JAK) Inhibitors Sales by Regions 2014-2019
2.2.2 Global Janus Kinase (JAK) Inhibitors Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Janus Kinase (JAK) Inhibitors Sales by Manufacturers
3.1.1 Janus Kinase (JAK) Inhibitors Sales by Manufacturers 2014-2019
3.1.2 Janus Kinase (JAK) Inhibitors Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Janus Kinase (JAK) Inhibitors Revenue by Manufacturers (2014-2019)
3.2.2 Janus Kinase (JAK) Inhibitors Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.3 Janus Kinase (JAK) Inhibitors Price by Manufacturers
3.4 Key Manufacturers Janus Kinase (JAK) Inhibitors Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Janus Kinase (JAK) Inhibitors Market
3.6 Key Manufacturers Janus Kinase (JAK) Inhibitors Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Autoimmune disorders Sales and Revenue (2014-2019)
4.1.2 Oncology Sales and Revenue (2014-2019)
4.2 Global Janus Kinase (JAK) Inhibitors Sales Market Share by Type
4.3 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type
4.4 Janus Kinase (JAK) Inhibitors Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Janus Kinase (JAK) Inhibitors Sales by Application

6 North America
6.1 North America Janus Kinase (JAK) Inhibitors Breakdown Data by Company
6.2 North America Janus Kinase (JAK) Inhibitors Breakdown Data by Type
6.3 North America Janus Kinase (JAK) Inhibitors Breakdown Data by Application
6.4 North America Janus Kinase (JAK) Inhibitors Breakdown Data by Countries
6.4.1 North America Janus Kinase (JAK) Inhibitors Sales by Countries
6.4.2 North America Janus Kinase (JAK) Inhibitors Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Janus Kinase (JAK) Inhibitors Breakdown Data by Company
7.2 Europe Janus Kinase (JAK) Inhibitors Breakdown Data by Type
7.3 Europe Janus Kinase (JAK) Inhibitors Breakdown Data by Application
7.4 Europe Janus Kinase (JAK) Inhibitors Breakdown Data by Countries
7.4.1 Europe Janus Kinase (JAK) Inhibitors Sales by Countries
7.4.2 Europe Janus Kinase (JAK) Inhibitors Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy

8 Asia Pacific
8.1 Asia Pacific Janus Kinase (JAK) Inhibitors Breakdown Data by Company
8.2 Asia Pacific Janus Kinase (JAK) Inhibitors Breakdown Data by Type
8.3 Asia Pacific Janus Kinase (JAK) Inhibitors Breakdown Data by Application
8.4 Asia Pacific Janus Kinase (JAK) Inhibitors Breakdown Data by Regions
8.4.1 Asia Pacific Janus Kinase (JAK) Inhibitors Sales by Countries
8.4.2 Asia Pacific Janus Kinase (JAK) Inhibitors Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea

9 Central & South America
9.1 Central & South America Janus Kinase (JAK) Inhibitors Breakdown Data by Company
9.2 Central & South America Janus Kinase (JAK) Inhibitors Breakdown Data by Type
9.3 Central & South America Janus Kinase (JAK) Inhibitors Breakdown Data by Application
9.4 Central & South America Janus Kinase (JAK) Inhibitors Breakdown Data by Countries
9.4.1 Central & South America Janus Kinase (JAK) Inhibitors Sales by Countries
9.4.2 Central & South America Janus Kinase (JAK) Inhibitors Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Janus Kinase (JAK) Inhibitors Breakdown Data by Type
10.2 Middle East and Africa Janus Kinase (JAK) Inhibitors Breakdown Data by Application
10.3 Middle East and Africa Janus Kinase (JAK) Inhibitors Breakdown Data by Countries
10.3.1 Middle East and Africa Janus Kinase (JAK) Inhibitors Sales by Countries
10.3.2 Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue by Countries
10.3.3 Mid East
10.3.4 South Africa

11 Company Profiles
11.1 Astellas Pharma, Inc.
11.1.1 Astellas Pharma, Inc. Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Janus Kinase (JAK) Inhibitors
11.1.4 Janus Kinase (JAK) Inhibitors Product Introduction
11.1.5 Astellas Pharma, Inc. Recent Development
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Janus Kinase (JAK) Inhibitors
11.2.4 Janus Kinase (JAK) Inhibitors Product Introduction
11.2.5 Eli Lilly and Co. Recent Development
11.3 Incyte Corp.
11.3.1 Incyte Corp. Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Janus Kinase (JAK) Inhibitors
11.3.4 Janus Kinase (JAK) Inhibitors Product Introduction
11.3.5 Incyte Corp. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Janus Kinase (JAK) Inhibitors
11.4.4 Janus Kinase (JAK) Inhibitors Product Introduction
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Janus Kinase (JAK) Inhibitors
11.5.4 Janus Kinase (JAK) Inhibitors Product Introduction
11.5.5 Pfizer Inc. Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Janus Kinase (JAK) Inhibitors Sales Channels
12.2.2 Janus Kinase (JAK) Inhibitors Distributors
12.3 Janus Kinase (JAK) Inhibitors Customers

13 Market Forecast
13.1 Global Janus Kinase (JAK) Inhibitors Sales and Revenue Forecast 2019-2025
13.2 Global Janus Kinase (JAK) Inhibitors Sales Forecast by Type
13.3 Global Janus Kinase (JAK) Inhibitors Sales Forecast by Application
13.4 Janus Kinase (JAK) Inhibitors Forecast by Regions
13.4.1 Global Janus Kinase (JAK) Inhibitors Sales Forecast by Regions 2019-2025
13.4.2 Global Janus Kinase (JAK) Inhibitors Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Janus Kinase (JAK) Inhibitors Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Janus Kinase (JAK) Inhibitors Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Janus Kinase (JAK) Inhibitors Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.8 Central & South America Market Forecast
13.8.1 Central & South America Janus Kinase (JAK) Inhibitors Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Forecast by Countries 2019-2025
13.9.2 Mid East
13.9.3 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Janus Kinase (JAK) Inhibitors Product Picture
Table Janus Kinase (JAK) Inhibitors Key Market Segments
Table Major Manufacturers Janus Kinase (JAK) Inhibitors Covered in This Report
Table Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Janus Kinase (JAK) Inhibitors Sales Market Shar by Type 2014-2025
Figure Autoimmune disorders Figures
Table Major Manufacturers of Autoimmune disorders
Figure Oncology Figures
Table Major Manufacturers of Oncology
Table Global Janus Kinase (JAK) Inhibitors Market Share by Application 2019-2025 (K Units)
Figure Clinics Use Case
Figure Hospitals Use Case
Figure Janus Kinase (JAK) Inhibitors Report Years Considered
Figure Global Janus Kinase (JAK) Inhibitors Market Size 2014-2025 (Million US$)
Figure Global Janus Kinase (JAK) Inhibitors Sales 2014-2019 (K Units)
Table Global Janus Kinase (JAK) Inhibitors Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Janus Kinase (JAK) Inhibitors Sales by Regions 2014-2019 (K Units)
Table Global Janus Kinase (JAK) Inhibitors Sales Market Share by Regions 2014-2019
Figure Global Janus Kinase (JAK) Inhibitors Sales Market Share by Regions 2014-2019
Figure Global Janus Kinase (JAK) Inhibitors Sales Market Share by Regions in 2018
Table Global Janus Kinase (JAK) Inhibitors Revenue by Regions 2014-2019 (Million US$)
Table Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Janus Kinase (JAK) Inhibitors Sales by Manufacturers (2014-2019) (K Units)
Table Global Janus Kinase (JAK) Inhibitors Sales Share by Manufacturers (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Sales Share by Manufacturers in 2018
Table Janus Kinase (JAK) Inhibitors Revenue by Manufacturers (2014-2019) (Million USD)
Table Janus Kinase (JAK) Inhibitors Revenue Share by Manufacturers (2014-2019)
Figure Janus Kinase (JAK) Inhibitors Value Share by Manufacturers in 2018
Table Global Janus Kinase (JAK) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Janus Kinase (JAK) Inhibitors Price (2014-2019) (USD/Unit)
Table Key Manufacturers Janus Kinase (JAK) Inhibitors Plants/Factories Distribution
Table Key Manufacturers Janus Kinase (JAK) Inhibitors Area Served
Table Date of Key Manufacturers Enter into Janus Kinase (JAK) Inhibitors Market
Table Key Manufacturers Janus Kinase (JAK) Inhibitors Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Autoimmune disorders Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Oncology Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Janus Kinase (JAK) Inhibitors Sales by Type (2014-2019) (K Units)
Table Global Janus Kinase (JAK) Inhibitors Sales Share by Type (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Sales Market Share by Type in 2018
Table Global Janus Kinase (JAK) Inhibitors Revenue by Type (2014-2019) (Million US$)
Table Global Janus Kinase (JAK) Inhibitors Revenue Share by Type (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type in 2018
Table Janus Kinase (JAK) Inhibitors Price by Type 2014-2019 (USD/Unit)
Table Global Janus Kinase (JAK) Inhibitors Sales by Application (2014-2019) (K Units)
Table Global Janus Kinase (JAK) Inhibitors Sales Share by Application (2014-2019)
Figure Global Sales Janus Kinase (JAK) Inhibitors Market Share by Application (2014-2019)
Figure Global Sales Janus Kinase (JAK) Inhibitors Market Share by Application in 2018
Figure North America Janus Kinase (JAK) Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure North America Janus Kinase (JAK) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table North America Janus Kinase (JAK) Inhibitors Sales by Company (2014-2019) (K Units)
Table North America Janus Kinase (JAK) Inhibitors Sales Market Share by Company (2014-2019)
Figure North America Janus Kinase (JAK) Inhibitors Sales Market Share by Company in 2018
Table North America Janus Kinase (JAK) Inhibitors Sales by Type (2014-2019) (K Units)
Table North America Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2014-2019)
Figure North America Janus Kinase (JAK) Inhibitors Market Share by Type in 2018
Table North America Janus Kinase (JAK) Inhibitors Sales by Application (2014-2019) (K Units)
Table North America Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2014-2019)
Figure North America Janus Kinase (JAK) Inhibitors Market Share by Application in 2018
Table North America Janus Kinase (JAK) Inhibitors Sales by Countries (2014-2019) (K Units)
Table North America Janus Kinase (JAK) Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America Janus Kinase (JAK) Inhibitors Sales Market Share by Countries in 2018
Table North America Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table North America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure United States Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Canada Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Europe Janus Kinase (JAK) Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Europe Janus Kinase (JAK) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Janus Kinase (JAK) Inhibitors Sales by Company (2014-2019) (K Units)
Table Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Company (2014-2019)
Figure Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Company in 2018
Table Europe Janus Kinase (JAK) Inhibitors Sales by Type (2014-2019) (K Units)
Table Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2014-2019)
Figure Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Type in 2018
Table Europe Janus Kinase (JAK) Inhibitors Sales by Application (2014-2019) (K Units)
Table Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2014-2019)
Figure Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Application in 2018
Table Europe Janus Kinase (JAK) Inhibitors Sales by Countries (2014-2019) (K Units)
Table Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Countries (2014-2019)
Figure Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Countries in 2018
Table Europe Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Europe Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure Germany Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure France Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure UK Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Italy Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Russia Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Janus Kinase (JAK) Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Janus Kinase (JAK) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales by Regions (2014-2019) (K Units)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales by Type (2014-2019) (K Units)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2014-2019)
Figure Asia Pacific Janus Kinase (JAK) Inhibitors Market Share by Type in 2018
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales by Application (2014-2019) (K Units)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2014-2019)
Figure Asia Pacific Janus Kinase (JAK) Inhibitors Market Share by Application in 2018
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific Janus Kinase (JAK) Inhibitors Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Janus Kinase (JAK) Inhibitors Revenue Market Share by Regions in 2018
Figure China Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure China Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Japan Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Korea Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure India Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure India Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Australia Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Janus Kinase (JAK) Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Janus Kinase (JAK) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Janus Kinase (JAK) Inhibitors Sales by Company (2014-2019) (K Units)
Table Central & South America Janus Kinase (JAK) Inhibitors Sales Market Share by Company (2014-2019)
Figure Central & South America Janus Kinase (JAK) Inhibitors Sales Market Share by Company in 2018
Table Central & South America Janus Kinase (JAK) Inhibitors Sales by Type (2014-2019) (K Units)
Table Central & South America Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2014-2019)
Figure Central & South America Janus Kinase (JAK) Inhibitors Market Share by Type in 2018
Table Central & South America Janus Kinase (JAK) Inhibitors Sales by Application (2014-2019) (K Units)
Table Central & South America Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2014-2019)
Figure Central & South America Janus Kinase (JAK) Inhibitors Market Share by Application in 2018
Table Central & South America Janus Kinase (JAK) Inhibitors Sales by Countries (2014-2019) (K Units)
Table Central & South America Janus Kinase (JAK) Inhibitors Sales Market Share by Countries (2014-2019)
Figure Central & South America Janus Kinase (JAK) Inhibitors Sales Market Share by Countries in 2018
Table Central & South America Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Central & South America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Type in 2018
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Application in 2018
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Countries in 2018
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure GCC Countries Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Figure Egypt Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Figure South Africa Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Janus Kinase (JAK) Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Table Astellas Pharma, Inc. Company Details
Table Astellas Pharma, Inc. Description and Business Overview
Table Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019)
Table Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Sales Market Share in Global Market
Table Astellas Pharma, Inc. Recent Development
Table Eli Lilly and Co. Company Details
Table Eli Lilly and Co. Description and Business Overview
Table Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019)
Table Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Sales Market Share in Global Market
Table Eli Lilly and Co. Recent Development
Table Incyte Corp. Company Details
Table Incyte Corp. Description and Business Overview
Table Incyte Corp. Janus Kinase (JAK) Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Incyte Corp. Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019)
Table Incyte Corp. Janus Kinase (JAK) Inhibitors Sales Market Share in Global Market
Table Incyte Corp. Recent Development
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG Janus Kinase (JAK) Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019)
Table Novartis AG Janus Kinase (JAK) Inhibitors Sales Market Share in Global Market
Table Novartis AG Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Description and Business Overview
Table Pfizer Inc. Janus Kinase (JAK) Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc. Janus Kinase (JAK) Inhibitors Sales Growth Rate (2014-2019)
Table Pfizer Inc. Janus Kinase (JAK) Inhibitors Sales Market Share in Global Market
Table Pfizer Inc. Recent Development
Figure Janus Kinase (JAK) Inhibitors Value Chain
Table Janus Kinase (JAK) Inhibitors Distributors List
Table Janus Kinase (JAK) Inhibitors Customers List
Table Global Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Forecast 2019-2025 (Million US$)
Table Global Janus Kinase (JAK) Inhibitors Sales Forecast by Type 2019-2025 (K Units)
Figure Global Janus Kinase (JAK) Inhibitors Sales Forecast by Type 2019-2025 (K Units)
Figure Global Janus Kinase (JAK) Inhibitors Sales Market Share Forecast by Type 2019-2025
Table Global Janus Kinase (JAK) Inhibitors Sales Forecast by Application 2019-2025 (K Units)
Figure Global Janus Kinase (JAK) Inhibitors Sales Forecast by Application 2019-2025 (K Units)
Figure Global Janus Kinase (JAK) Inhibitors Sales Market Share Forecast by Application 2019-2025
Table Global Janus Kinase (JAK) Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Janus Kinase (JAK) Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Janus Kinase (JAK) Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Global Janus Kinase (JAK) Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Table North America Janus Kinase (JAK) Inhibitors Sales Forecast by Countries 2019-2025 (K Units)
Table North America Janus Kinase (JAK) Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table North America Janus Kinase (JAK) Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Janus Kinase (JAK) Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure United States Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Canada Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Mexico Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Table Europe Janus Kinase (JAK) Inhibitors Sales Forecast by Countries 2019-2025 (K Units)
Table Europe Janus Kinase (JAK) Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Europe Janus Kinase (JAK) Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Janus Kinase (JAK) Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure France Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure UK Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Italy Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Janus Kinase (JAK) Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Janus Kinase (JAK) Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure China Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure Japan Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure South Korea Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Table Central & South America Janus Kinase (JAK) Inhibitors Sales Forecast by Countries 2019-2025 (K Units)
Table Central & South America Janus Kinase (JAK) Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Janus Kinase (JAK) Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Janus Kinase (JAK) Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure Mid East Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Figure South Africa Janus Kinase (JAK) Inhibitors Sales Forecast 2019-2025 (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Astellas Pharma, Inc.、Eli Lilly and Co.、Incyte Corp.、Novartis AG、Pfizer Inc.

★調査レポート[世界のヤヌスキナーゼ（JAK）阻害剤産業：成長傾向・競合分析2019-2025] (コード：DATA909X01275)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヤヌスキナーゼ（JAK）阻害剤産業：成長傾向・競合分析2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のホスホジエステラーゼ（PDE）阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01764 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のホスホジエステラーゼ（PDE）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ホスホジエステラーゼ（PDE）阻害剤の種類別には、PDE1選択的阻害剤、PDE2選択的阻害剤、PDE3選択的阻害剤、PDE4選択的阻害剤、PDE5選択的阻害剤、PDE7選択的阻害剤、PDE10選択的阻害剤に、用途別には、経口、局所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・ホスホジエステラーゼ（PDE）阻害剤の種類別市場規模：PDE1選択的阻害剤、PDE2選択的阻害剤、PDE3選択的阻害剤、PDE4選択的阻害剤、PDE5選択的阻害剤、PDE7選択的阻害剤、PDE10選択的阻害剤 ・ホスホジエステラーゼ（PDE）阻害剤の用途別市場規模：経口、局所、その他 ・ホスホジエステラーゼ（PDE）阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Bayer AG、Eli Lilly...A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s). PDE inhibitor drugs are also used to treat various other medical conditions such as autoimmune indications, ulcerative colitis, and others. However, the increasing incidence of ED across the world will boost the global phosphodiesterase inhibitors market growth during the forecast period. In 2018, the global Phosphodiesterase (PDE) inhibitors market size was xx million US$ and is forecast...
  • 世界のBRAFキナーゼ阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X00353 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のBRAFキナーゼ阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。BRAFキナーゼ阻害剤の種類別には、ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブに、用途別には、病院、医学研究所、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・BRAFキナーゼ阻害剤の種類別市場規模：ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブ ・BRAFキナーゼ阻害剤の用途別市場規模：病院、医学研究所、クリニック、その他 ・BRAFキナーゼ阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Array BioPharma Inc.、Bayer...BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.These drugs directly target BRAF protein and inhibit the growth of tumors in patients with metastatic melanoma. Such results delivered by the BRAF kinase inhibitors has encouraged several R&D teams to extend research on other applications. Moreover, many BRAF kinase inhibitor drugs are in the final stages of development and are expected to be launched during the forecast period. In 2018, the global BRAF Kinase Inhibitors market size was xx million US$ and...
  • 世界のMEK阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01476 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のMEK阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。MEK阻害剤の種類別には、メキニスト、コテリック、メクトビに、用途別には、NSCLC、がんに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・MEK阻害剤の種類別市場規模：メキニスト、コテリック、メクトビ ・MEK阻害剤の用途別市場規模：NSCLC、がん ・MEK阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AstraZeneca Plc、F. Hoffmann-La...A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.In 2018, the global MEK Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for MEK Inhibitors. This study researches the market size of MEK Inhibitors, presents the global MEK Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014...
  • 世界の有毛細胞白血病治療産業：成長傾向・競合分析2019-2025
    DATA909X01057 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の有毛細胞白血病治療市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。有毛細胞白血病治療の種類別には、化学療法薬、標的阻害剤に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・有毛細胞白血病治療の種類別市場規模：化学療法薬、標的阻害剤 ・有毛細胞白血病治療の用途別市場規模：クリニック、病院 ・有毛細胞白血病治療の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AstraZeneca Plc、F. Hoffmann-La...Hairy cell leukemia is a slow-growing, rare type of chronic cell leukemia.In 2018, the global Hairy Cell Leukemia Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hairy Cell Leukemia Drugs. This study researches the market size of Hairy Cell Leukemia Drugs, presents the global Hairy Cell Leukemia Drugs sales and revenue by companies, regions, type and application, history breakdown...
  • 世界の皮膚炎薬産業：成長傾向・競合分析2019-2025
    DATA909X00652 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の皮膚炎薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。皮膚炎薬の種類別には、カルシニューリン阻害剤、コルチコステロイド、生物製剤、その他に、用途別には、病院薬局、小売薬局、オンライン薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・皮膚炎薬の種類別市場規模：カルシニューリン阻害剤、コルチコステロイド、生物製剤、その他 ・皮膚炎薬の用途別市場規模：病院薬局、小売薬局、オンライン薬局 ・皮膚炎薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Regeneron、Bausch Health、Astellas Pharma、Pfizer、Mylan、Bayer、Allergan、LEO...Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash.In 2018, the global Dermatitis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatitis Drugs. This study researches the market size of Dermatitis Drugs, presents the global Dermatitis Drugs sales and revenue by companies, regions, type and application, history breakdown...
  • 世界のパラフェニルフェノール産業：成長傾向・競合分析2019-2025
    DATA909X01707 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のパラフェニルフェノール市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。パラフェニルフェノールの種類別には、純度≥99％、純度...The Para Phenyl Phenol market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Para Phenyl Phenol. This study focuses on the production side and consumption side of Para Phenyl Phenol, presents the global Para Phenyl Phenol market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. In...
  • 世界の4-フェニルフェノール産業：成長傾向・競合分析2019-2025
    DATA909X00029 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の4-フェニルフェノール市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。4-フェニルフェノールの種類別には、純度≥99％、純度...The 4-Phenylphenol market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for 4-Phenylphenol. This study focuses on the production side and consumption side of 4-Phenylphenol, presents the global 4-Phenylphenol market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. In terms of production side, this report researches the...

    • ◆H&Iグローバルリサーチのお客様（例）◆